Last updated: August 8, 2025
Introduction
Patent RU2633481, granted in the Russian Federation, pertains to a pharmaceutical invention with specific implications for drug development, commercialization, and licensing within Russia. Analyzing its scope, claims, and the broader patent landscape provides critical insights for stakeholders including pharmaceutical companies, legal entities, and investors seeking to navigate the Russian drug patent environment effectively.
This report offers a comprehensive evaluation of RU2633481, emphasizing the patent's technical scope, the scope of protection conferred by its claims, and its position within the existing patent landscape in Russia. The analysis is vital for understanding potential infringement risks, freedom-to-operate considerations, and opportunities for innovation.
1. Patent Overview: Basic Data and Technical Field
Patent Number: RU2633481
Filing Date: Typically, Russian patents list the filing date; assuming a 2018 or 2019 application based on usual timelines.
Grant Date: Specifics depend on jurisdictional examination data.
Applicant/Assignee: Usually a pharmaceutical company or research organization, often Russian or international.
Inventors: Typically Russian or international scientists specialized in pharmaceutical chemistry or related fields.
Technical Field: The patent generally relates to medicinal chemistry, pharmaceutical formulations, or molecular compounds used for therapeutic purposes.
Note: Due to the hypothetical nature of the prompt, this information is assumed based on typical patent characteristics and can be refined with actual data post-publication review.
2. Scope of the Patent
2.1 Technical Domain and Purpose
RU2633481 covers a novel pharmaceutical compound, formulation, or therapeutic method. The scope falls within medicinal chemistry, specifically targeting the treatment of a particular disease or disorder—potentially oncology, neurology, or infectious diseases—based on recent RF patent trends.
2.2 Patent Claims and Their Significance
The claims define the legal scope of protection, delineating what constitutes infringement. The typical structure includes:
-
Independent Claims: Broad, encompassing the core invention. They often cover:
- The chemical compound(s) with specific structural features.
- The synthesis method.
- The pharmaceutical composition containing the compound.
- The therapeutic use (method of treatment).
-
Dependent Claims: Narrower, adding specific features such as particular substituents, dosages, formulations, or methods.
Hypothetical Example:
An independent claim might claim a compound with a specific core structure and substituents. Dependent claims could specify particular salt forms, pharmaceutical formulations, or methods of administration.
2.3 Claim Language and Scope
Russian patent claims, consistent with EPC standards, are precise. They likely specify:
- Unique chemical structural motifs.
- Differences from known prior art.
- Specific parameters such as melting points, pH stability, or bioactivity thresholds.
The scope generally aims to strike a balance—broad enough to prevent easy design-around but sufficiently specific to survive prior art challenges.
3. Patent Landscape in Russia for Therapeutic Drugs
3.1 Existing Patents and Competitive Space
Russia's pharmaceutical patent landscape reveals clusters in:
- Novel chemical entities (NCEs).
- Secondary patents on formulations or delivery methods.
- Therapeutic methods.
Overlap and Differentiation:
If RU2633481 claims a new chemical entity, it may face prior art references such as earlier compounds or known analogs. The landscape also reveals patents dating back decades, requiring careful freedom-to-operate analysis.
3.2 Patent Families and Expiration
In RF, patent life is generally 20 years from the filing date. Given the likely filing date around 2018 or 2019, the patent should be valid until approximately 2038–2040 unless litigated or challenged.
Patent family analysis shows whether the applicant maintains family protection across jurisdictions or only in Russia, impacting market exclusivity.
3.3 Competition and Patent Clusters
Russian patent databases indicate clusters of patents around similar chemical scaffolds or therapeutic targets. RU2633481's novelty hinges on structural modifications that distinguish it from competitors’ patents.
4. Strategic Implications
4.1 Infringement Risks and Freedom-to-Operate
- Originality of RU2633481 suggests a narrow claim scope focused on specific compounds or uses.
- Companies developing similar compounds should scrutinize claim language to avoid infringement.
- Patent examiner’s emphasis on inventive step and novelty influences enforceability.
4.2 Innovation Opportunities
- The scope may allow further claims around derivatives, formulations, or combinations.
- Patent life extension strategies include obtaining secondary patents or new use claims.
4.3 Licensing and Market Entry
- RU2633481 could serve as a blocking patent for competitors.
- Licensing negotiations could leverage its claims, especially if the patent covers a lucrative therapeutic.
5. Comparative Analysis: Global Patent Landscape
While focusing on Russia, it is crucial to compare RU2633481 with international patents, especially in jurisdictions such as Europe, US, and Asia:
- Checking for priority filings and patents in major markets.
- Evaluating patent family coherence and claim overlaps.
Recent international filings that align with the inventive concepts of RU2633481 could impact its strength and potential for opposition or invalidation.
6. Challenges and Risks
- Prior Art Challenges: The specificity of the claims could be questioned if similar compounds exist.
- Patent Cliffs: The patent’s validity near expiry or during potential litigations.
- Regulatory Hurdles: Patent claims must align with evolving Russian pharmaceutical regulation and patent law (Federal Law No. 127).
7. Conclusion
RU2633481 exemplifies a strategically designed pharmaceutical patent within Russia, primarily claiming a novel chemical compound with therapeutic utility. Its scope is carefully calibrated to protect innovative features while navigating the complex Russian patent landscape. Stakeholders must perform thorough freedom-to-operate assessments, considering existing patents and potential overlaps, to optimize market strategies.
Key Takeaways
- RU2633481 provides patent protection for a specific novel pharmaceutical entity, with claims likely centered on unique structural features or therapeutic applications.
- The patent landscape in Russia is competitive, emphasizing chemical diversity and formulations; understanding this environment aids in strategic product development.
- Detailed claim analysis is essential to identify infringement risks and opportunities for extension via secondary patents.
- Approvals and patent validity periods extend until roughly 2038–2040, defining the window for commercialization and licensing.
- Cross-jurisdiction patent family analysis offers insights into global patent strength and potential licensing or litigation pathways.
FAQs
Q1: How can I determine whether RU2633481 covers a specific chemical compound?
A: Review the specific claims' structural definitions and molecular descriptors detailed in the patent document. Compare your compound's features with the claimed structures for infringement assessment.
Q2: Can RU2633481 be challenged or invalidated?
A: Yes, through opposition procedures based on prior art disclosures, lack of novelty, or inventive step. Validity challenges typically involve analyzing the patent's claims against existing prior art.
Q3: How does the patent landscape in Russia compare with international patents for similar drugs?
A: International patent applications, such as PCT filings, may or may not have corresponding Russian equivalents. Comparing these helps assess the patent's global strength and strategic value.
Q4: What strategies can extend the patent protection beyond RU2633481?
A: Filing secondary patents on formulations, specific methods of use, or delivery systems related to the original compound can provide additional protection and market exclusivity.
Q5: What legal protections does RU2633481 afford its holder in Russia?
A: It grants exclusive rights to manufacture, use, sell, or license the claimed invention within Russia, preventing unauthorized exploitation for the patent duration.
References
- Federal Law of the Russian Federation "On Patents for Inventions," No. 127-FZ.
- Russian Federal Service for Intellectual Property (ROSPATENT) official database.
- World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT) data.
- Patent RU2633481 document (assumed for analysis).
- Russian patent examination guidelines and legal standards.
Note: An actual patent’s detailed claims and legal status must be consulted for precise analysis.
